Efti + KEYTRUDA combo shows strong efficacy for NSCLC patients in Immutep's phase 1 study. Read why IMMP stock may see upside ...

Anti-amyloid antibodies lecanemab and donanemab are in clinical use now, but that does not mean research on them has stopped. At the Clinical Trials on Alzheimer’s Disease conference, held October ...

Objectives Secondary prevention of rheumatoid arthritis (RA) is generally considered potentially impactful because the entire ...

Significant year-to-year fluctuations in cholesterol levels without changes in medication may indicate that older adults have a higher risk for cognitive decline or dementia, according to preliminary ...

The aim of this study is to examine ‘how’ leadership influences ... (Focus Group, C017) When leaders did not follow through, followers became frustrated and often gave up asking for support, impeding ...

Just 15% of patients have their filters taken out despite clear recommendations they should be removed as soon as feasible.

New research indicates that people with cardiovascular-kidney-metabolic syndrome may have a higher risk of developing ...

Members' Club tipping is our top-tier betting advice service, starring our biggest and best experts. This and lots more exclusive insight is published every night on racingpost.com from 6pm. Members' ...

With a positive readout for metabolic dysfunction-associated steatohepatitis (MASH) now in the bag, Novo Nordisk is gearing up to pursue yet ... 34.1% of patients in the study’s control cohort.

with exports reduced by $44.8 billion should Trump win next week’s election and follow through with his pledge to impose universal tariffs — at a maximum level, according to the study released ...